Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for USANA Health Sciences, Inc. (USNA : NYSE)

• Company Description    USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system. Number of Employees: 1,700

• Price / Volume Information    Yesterday's Closing Price: $33.41 Daily Weekly Monthly 20 Day Moving Average: 144,662 shares Shares Outstanding: 18.62 (millions) Market Capitalization: $622.20 (millions) Beta: 0.64 52 Week High: $48.85 52 Week Low: $23.10 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 12.19% 7.99% 12 Week 40.73% 18.38% Year To Date -6.91% -12.82%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3838 West Parkway Blvd - Salt Lake City,UT 84120 USA ph: 801-954-7100 fax: 801-954-7300 investor.relations@usanainc.com http://www.usana.com

• General Corporate Information    Officers Jim H. Brown - Chief Executive Officer and President Kevin G. Guest - Executive Chairman of the Board G. Douglas Hekking - Chief Financial Officer Gilbert A. Fuller - Director John T. Fleming - Director Peer Information USANA Health Sciences, Inc. (GSAC) USANA Health Sciences, Inc. (CASI) USANA Health Sciences, Inc. (ALCD.) USANA Health Sciences, Inc. (OMNN) USANA Health Sciences, Inc. (CGPI.) USANA Health Sciences, Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 90328M107 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 07/22/25 Share - Related Items Shares Outstanding: 18.62 Most Recent Split Date: 11.00 (2.00:1) Beta: 0.64 Market Capitalization: $622.20 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.65 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $2.61 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 12.00% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 07/22/25

• Fundamental Ratios P/E Current FY Estimate: 12.80 Trailing 12 Months: 13.53 PEG Ratio: 1.07 Price Ratios Price/Book: 1.19 Price/Cash Flow: 8.85 Price / Sales: 0.71 EPS Growth vs. Year Ago Period: -15.12% vs. Previous Quarter: 14.06% Sales Growth vs. Year Ago Period: 9.54% vs. Previous Quarter: 16.82% ROE 06/30/25 - - 03/31/25 - 8.94 12/31/24 - 9.57 ROA 06/30/25 - - 03/31/25 - 6.74 12/31/24 - 7.42 Current Ratio 06/30/25 - - 03/31/25 - 2.05 12/31/24 - 2.00 Quick Ratio 06/30/25 - - 03/31/25 - 1.51 12/31/24 - 1.50 Operating Margin 06/30/25 - - 03/31/25 - 5.38 12/31/24 - 5.82 Net Margin 06/30/25 - - 03/31/25 - 3.98 12/31/24 - 4.92 Pre-Tax Margin 06/30/25 - - 03/31/25 - 7.53 12/31/24 - 8.94 Book Value 06/30/25 - - 03/31/25 - 28.09 12/31/24 - 27.92 Inventory Turnover 06/30/25 - - 03/31/25 - 2.54 12/31/24 - 2.51 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 9.27 12/31/24 - 9.25

Powered by Zacks Investment Research ©